Global point of care
When it comes to diagnosis and treatment, every moment matters. Diagnostic innovations such as C-reactive protein (CRP) point-of-care testing can help to inform decision making* – making the most of time for both the doctor and patient, as well as reducing unnecessary antibiotic prescribing.1-10 Afinion CRP is part of Abbott’s commitment to making every minute count in patient care.
Time is ticking in the battle against antimicrobial resistance (AMR). It’s a serious healthcare and economic problem. Overuse of antibiotics is a key driver of AMR and limits future effectiveness of treatments for tackling infection.1,11
Watch this video to learn how diagnostics innovations such as C-reactive protein (CRP) Point of Care Testing can help in the fight against Antimicrobial Resistance (AMR).
C-reactive protein (CRP) is a major acute phase biomarker, which can be used to differentiate between self-limiting or viral and severe bacterial infections, and helps HCPs to identify patients with RTIs who would benefit from antibiotics, and those who would not.1-10
In a number of studies, CRP POC testing has been found to:
Help resolve diagnostic uncertainty in patients with RTIs when used alongside clinical observation of signs and symptoms. 1,2,5,12
Reduce antibiotic prescribing for RTIs by as much as 23-42%3,5,6,13
Reduce antibiotic prescribing by GPs by more than 60% when combined with enhanced communication skills3,6
Atypical presentation and fewer presenting signs and symptoms in older patients complicate diagnosis and delay initiation of adequate treatment.15
However, several studies have confirmed the usefulness of CRP testing in geriatric patients.15-18
Download the Afinion CRP brochure to learn how CRP testing at the point of care can transform your consultations and help to guide antibiotic prescribing in adult and geriatric patients.
The Afinion CRP cartridge has been made with an all-in-one, user-friendly design – and with no pre-analytical handling required, achieving accurate results is even simpler.
At Abbott, we are committed to #makeeveryminutecount and we can serve you and our common mission to reduce AMR and #keepantibioticsworking with Afinion CRP. To find out more about Abbott, follow us on social media:
Afinion CRP is a rapid, in vitro diagnostic test that helps reduce diagnostic uncertainty and guide antibiotic decision-making at the point of care.
*As with most other diagnostic tests, CRP results should always be combined with clinical findings when deciding upon treatment.
1. Cooke J et al. Straight to the point: A consensus report 2015.
2. Aabenhus R et al. Cochrane Database of Systematic Reviews 2014; 11; Art. No.: CD010130.
3. Cals, JW, et al. BMJ. 2009;338(51):137.
4. Tonkin-Crine SG, et al. Cochrane Database of Systematic Reviews 2017, Issue 9. Art. No.: CD012252.
5. Andreeva E, Melbye H. BMC Family Practice 2014; 15(1):80.
6. Little P, et al. The Lancet 2013; 382(9899):1175-1182.
7. Bjerrum L, et al. Ugeskr Laeger. 2005; 167:2775-2777.
8. Cals JWL et al. Journal of Evaluation in Clinical Practice 2011; 17: 1059–1069.
9. Hopstaken R, et al. Br J Gen Pract 2003; 53(490):358-364.
10. Strykowski DF, et al. Family Practice 2015; 32(4): 395–400.
11. O’Neill J. Review on antimicrobial resistance. 2016.
12. Cooke J, et al. BMJ open respiratory research. 2015 May 1; 2(1):e000086.
13. Cals JWL, et al. The Annals of Family Medicine. 2010;8(2):124-133.
14. Nouvenne A et al. BMC Geriatrics 2016; 16:16.
15. Arinzon Z, et al. Archives of gerontology and geriatrics. 2011 Nov 1;53(3):364-9.
16. Liu A, et al. Age and ageing. 2010 Jun 23;39(5):559-65.
17. Porfyridis II et al. Respiratory care. 2014 Apr 1;59(4):574-81.
18. Ticinesi A et al. European Journal of Internal. 28. Medicine 2017; 37: 7–12.
19. Boere T, et al. Using Point-of-care C-reactive protein to guide Antibiotic prescribing for Respiratory tract infections in Elderly nursing home residents (UPCARE) (WC2017-001).